Home › Atopic Dermatitis (Eczema) › West Virginia › Morgantown
Atopic Dermatitis (Eczema) clinical trials in Morgantown, WV
4 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in and around Morgantown (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
RecruitingObservational study
- West Virginia Research Institute, Morgantown
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
RecruitingPhase 3
- West Virginia University Hospitals /ID# 265114, Morgantown
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
RecruitingPhase 3
- West Virginia Research Institute - Morgantown /ID# 264930, Morgantown
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
RecruitingObservational study
- Galderma Investigational Site 8725, Morgantown
Atopic Dermatitis (Eczema) trials in other cities
- New York City, NY13 studies
- Los Angeles, CA11 studies
- Washington, DC11 studies
- San Diego, CA10 studies
- San Antonio, TX10 studies
- Miami, FL9 studies
- Birmingham, AL9 studies
- Troy, MI8 studies
- Dallas, TX8 studies
- Huntington Beach, CA8 studies
- Sacramento, CA8 studies
- Tampa, FL7 studies
Other studies in Morgantown
- Breast Cancer10 studies
- Non-Small Cell Lung Cancer10 studies
- Ovarian Cancer10 studies
- Cardiovascular Disease8 studies
- Lung Cancer6 studies
- Metastatic Cancer6 studies
- Cancer (all types)6 studies
- Heart Failure6 studies
- Colon Cancer5 studies
- Melanoma5 studies
- Migraine5 studies
- Obesity4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.